Narcolepsy: One Thing Leads to Another

Few other sayings could hold more accurate with narcolepsy, according to the Burden of Narcolepsy Disease (BOND).

Conducted with the use of medical and expense records from some 9,312 narcoleptic patients in the United States, the BOND study explored the co-morbidity rate associated with narcolepsy; what researchers found left them shaken, not stirred.

Regarding psychiatric comorbidity, narcolepsy patients were found to also suffer from depressive and anxiety disorders and to greater excess than those within the control group of approximately 46,559 individuals. Furthermore, all mental illness was found to be more prevalent in those with narcolepsy and psychiatric medication usage, office visits and costs related to mental illness were noted to be significantly higher in those with the condition as well.

Read more at:

Armando - Thank you for sharing this information. It explains not only the difficulties involved in getting a diagnosis but the reason why insurance companies fight against paying for short-term and long-term disability benefits for those patients who have co-morbidity issues. It''s a question of which came first, the chicken or the egg. There is a test that determines whether you have the genetic marker for narcolepsy but getting a positive result doesn't necessarily mean a patient will develop narcolepsy. We are costing the insurance companies money, and, if there's one thing insurance companies don't like, it's paying for multiple conditions.